Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2400047	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(2.2)	New Drug Application	2024-01-20		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSB2400005	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products	Supplementary Application	2024-01-13		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSS2300091	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(2.2)	New Drug Application	2023-12-06		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSB2300055	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(1)	Supplementary Application	2023-05-23		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSB2200103	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products	Supplementary Application	2022-12-08		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSB2200095	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products	Supplementary Application	2022-11-05		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSB2200037	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(1)	Supplementary Application	2022-04-21		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSS2101063	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(2.2)	New Drug Application	2021-12-15		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CYSB2101259	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(1)	Supplementary Application	2021-11-09		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSL2101385	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(2.2)	New Drug Application	2021-10-26		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSL2101340	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(2.2)	New Drug Application	2021-09-23		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSL2101321	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(2.2)	New Drug Application	2021-09-13		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSL2101254	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(2.2)	New Drug Application	2021-08-11		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSL2101244	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(2.2)	New Drug Application	2021-08-09		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSB2101024	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products	Supplementary Application	2021-07-08		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSB2101023	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(1)	Supplementary Application	2021-06-25		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSB2101020	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products	Supplementary Application	2021-06-22		Suzhou Suncadia Biopharmaceuticals Co Ltd			view
CXSS2100031	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(2.2)	New Drug Application	2021-03-26	苏州盛迪亚生物医药有限公司	Suzhou Suncadia Biopharmaceuticals Co Ltd	Certificate Completed-Pending Issued	2021-12-10	view
CXSS2100032	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(2.2)	New Drug Application	2021-03-26	苏州盛迪亚生物医药有限公司	Suzhou Suncadia Biopharmaceuticals Co Ltd	Certificate Completed-Pending Issued	2021-12-10	view
CYSB2100072	注射用卡瑞利珠单抗	camrelizumab	Lyophilized	Biological Products(1)	Supplementary Application	2021-03-19	苏州盛迪亚生物医药有限公司	Suzhou Suncadia Biopharmaceuticals Co Ltd	In Review	2021-03-18	view